Indefinite Delivery Contract 75F40118D10021

The Department of Health and Human Services Food and Drug Administration awarded multiple indefinite delivery contracts under the BEST Initative - Data Sources For Surveillance of Biologics master IDIQ. Iqvia Government Solutions Inc. received two delivery orders totaling $20 million to provide data sources and products/services in support of the BIOLOGICS EFFECTIVENESS AND SAFETY INITIATIVE #3 effort. Performance will take place in Mosby, Virginia over periods from September 2020 through...

The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a multiple-award indefinite-delivery indefinite-quantity (IDIQ) contract for the Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics. The prime contractor, The Lewin Group, Inc. (doing business as Lewing Group Inc.), a subsidiary of UnitedHealth Group Incorporated, will provide data sources containing administrative claims data or claims and electronic...

This is a $75 million multiple-award Indefinite Delivery Contract (IDC) awarded by the Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) to Iqvia Government Solutions Inc. for the Biologics Effectiveness and Safety (BEST) Initiative #3: Health Care Data Sources for Surveillance of Biologics (BEST 3). Under this IDC, Iqvia will provide the FDA with access to large-scale, longitudinal healthcare data from the United States covering tens of millions of...

The Department of Health and Human Services Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract under the BEST (Biologics Effectiveness and Safety) Initiative to CVS Health Clinical Trial Services LLC, a subsidiary of CVS Health Corporation. The contract, with a $50 million ceiling value and performance period through September 2025, is for the procurement of data sources to support the FDA's surveillance of biologics. Two task orders have been awarded to date under this...

This Indefinite Delivery Contract was awarded by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) to support the Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative. The contract aims to develop new and innovative methods for automated reporting for CBER-regulated biological products. The contract has a total ceiling value of $37.9 million and is structured as a multiple award, time and materials...

The Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) has awarded an Indefinite Delivery Contract (IDC) valued at up to $75 million to Acumen LLC, doing business as Medric, to support the Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics (BEST 3). The contract will provide CBER with access to large-scale, longitudinal healthcare data covering tens of millions of patients, including both administrative claims...

The key products and services being delivered under this federal contract IDV award are data sources and analytics to support the Food and Drug Administration's (FDA) Biologics Effectiveness and Safety (BEST) Initiative. The prime contractor, CVS Healthspire Payor & Life Sciences LLC, a subsidiary of CVS Health Corporation, was awarded a $50 million multiple award IDV to provide healthcare data and conduct safety analyses for the BEST program. Under a $1.38 million task order, CVS...

The Indefinite Delivery Contract (IDC) with ID 75F40118D10032 was awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc. under the Biologics Effectiveness and Safety (BEST) Initiative. The $75 million multiple-award contract aims to develop new and innovative methods for automated reporting of CBER-regulated biological products. Iqvia Government Solutions, a leading provider of healthcare data and analytics services to federal agencies, will deliver a range of...

This Blanket Purchase Agreement (BPA) was awarded by the National Institutes of Health (NIH) to Bioivt, LLC, a leading global provider of high-quality biological specimens and value-added services. The $1 billion BPA has a period of performance from May 2023 to January 2026 and is for the procurement of biological materials, blood, and blood products in support of medical research programs across federal agencies. Through this IDV, Bioivt will provide a variety of biological materials, including...

The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) has awarded a $20 billion Indefinite Delivery Contract to Advanced Technology International (ATI), a public service nonprofit, to establish and manage the Biopharmaceutical Manufacturing Preparedness Consortium (BIOMAP-Consortium). The consortium aims to build domestic manufacturing capabilities for medical countermeasures like vaccines, therapeutics, and personal...